Application of the heart failure meta-score to predict prognosis in patients with cardiac resynchronization
Dominic A M J Theuns1, Beat A Schaer2, Kadir Caliskan1
1Dept. of Cardiology, Erasmus MC, Rotterdam, the Netherlands.
Insights
The Heart Failure (HF) Meta-score effectively predicts survival in patients receiving cardiac resynchronization defibrillators (CRT-D) for primary prevention. This score identifies high-risk individuals who may not benefit from CRT-D therapy.
Area of Science:
- Cardiology
- Medical Prognostics
Background:
- The Heart Failure (HF) Meta-score's utility in predicting prognosis for primary prevention cardiac resynchronization defibrillators (CRT-D) patients is under investigation.
- Considering competing risks of appropriate defibrillator shock versus mortality is crucial for accurate prognostic assessment.
Purpose of the Study:
- To evaluate the performance of the HF Meta-score in predicting outcomes in patients with primary prevention CRT-D.
- To assess the score's ability to predict mortality and the combined endpoint of death or appropriate implantable cardioverter-defibrillator (ICD) shock.
Main Methods:
- Retrospective analysis of data from 648 consecutive patients across two centers.
- Utilized the Fine-Gray model for competing risk regression analysis.
- Primary endpoint: mortality; Secondary endpoint: time to first appropriate ICD shock or death without prior appropriate ICD shock.
Main Results:
- Over a median of 5.2 years, 237 patients died. Five-year mortality incidence ranged from 12% to 53% across HF Meta-score quintiles.
- The highest quintile showed a significantly higher mortality risk (HR 6.9) compared to the lowest.
- The HF Meta-score demonstrated excellent calibration and discrimination for mortality prediction (C-statistic 0.76 at 1-year, 0.71 at 5-year).
Conclusions:
- The HF Meta-score effectively predicts survival in heart failure patients treated with CRT-D for primary prevention.
- The score is valuable for identifying patients with a poor prognosis despite CRT-D implantation.
Background:
The Heart Failure (HF) Meta-score may be useful in predicting prognosis in patients with primary prevention cardiac resynchronization defibrillators (CRT-D) considering the competing risk of appropriate defibrillator shock versus mortality.
Methods:
Data from 648 consecutive patients from two centers were used for the evaluation of the performance of the HF Meta-score. The primary endpoint was mortality and the secondary endpoint was time to first appropriate implantable cardioverter-defibrillator (ICD) shock or death without prior appropriate ICD shock. Fine-Gray model was used for competing risk regression analysis.
Results:
In the entire cohort, 237 patients died over a median follow-up of 5.2 years. Five-year cumulative incidence of mortality ranged from 12% to 53%, for quintiles 1 through 5 of the HF Meta-score, respectively (log-rank P < 0.001). Compared with the lowest quintile, mortality risk was higher in the highest quintile (HR 6.9; 95%CI 3.7-12.8). The HF Meta-score had excellent calibration, accuracy, and good discrimination in predicting mortality (C-statistic 0.76 at 1-year and 0.71 at 5-year). The risk of death without appropriate ICD shock was higher in risk quintile 5 compared to quintile 1 (sub HR 5.8; 95%CI 3.1-11.0, P < 0.001).
Conclusions:
Our study demonstrated a good ability of the HF Meta-score to predict survival in HF patients treated with CRT-D as primary prevention. The HF Meta-score proved to be useful in identifying a subgroup with a significantly poor prognosis despite a CRT-D.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure V: Medical Management
Pathophysiology of Heart Failure
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VI: Adjunct Therapies
Heart Failure II: Pathophysiology
